Jeffrey Switchenko
机构: Research Associate Professor of Biostatistics and Bioinformatics, Emory University
每年引用次数
引用次数
引用: 4,273
H-指数: 34
I10-指数 : 119
出版物: 524
Multi‐center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era
Reem Karmali , Jeffrey M Switchenko , Subir Goyal , Krithika Shanmugasundaram
American journal of hematology 96 ( 11) 1374 -1384
19
2021
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey
R Andrew Harkins , Sharvil P Patel , Michelle J Lee , Jeffrey M Switchenko
Blood advances 6 ( 9) 2745 -2756
4
2022
Complex karyotype predicts the prognostics impact of WBC count in untreated mantle cell lymphoma and is associated with shortened survival independent of specific cytogenetic abnormalities
Irl Brian Greenwell , Jeffrey M Switchenko , Ashley D Staton , Debra Saxe
Blood 130 1499 -1499
2
2017
Impact of multi-agent systemic therapy on all-cause and disease-specific survival for people living with HIV who are diagnosed with non-Hodgkin lymphoma: population-based analyses from the state of Georgia
Joseph Lipscomb , Jeffrey M Switchenko , Christopher R Flowers , Theresa W Gillespie
Leukemia & lymphoma 64 ( 1) 151 -160
1
2023
Ki-67 Expression of 50% Is the Optimal Cut-Off to Predict Survival Outcomes in Mantle Cell Lymphoma (MCL): A Pooled Analysis from CALGB 50403 (Alliance) and MCL Real-World Study Cohort
Narendranath Epperla , Jeffrey M Switchenko , Susan M Geyer , Veronika Bachanova
Blood 142 380 -380
2023
An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma
Yucai Wang , Melissa C Larson , Umar Farooq , Sara Ekberg
Blood 142 1656 -1656
2023
Overall Survival Following First and Second Relapse of DLBCL Treated with Therapies Including Autologous Transplant and CAR-T Cells: Results from the Lion Prospective Observational Registry
Greg Kirkpatrick , Jeffrey M Switchenko , Melissa Kives , Katelin Baird
Blood 142 6325 -6325
2023
Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry
David A Bond , Jason T Romancik , Jeffrey M Switchenko , Brielle Berkowitz
Blood 140 ( Supplement 1) 6509 -6511
2022
Treatment outcomes and roles of transplantation and maintenance rituximab in patients with previously untreated mantle cell lymphoma: results from large real-world cohorts
Peter Martin , Jonathon B Cohen , Michael Wang , Anita Kumar
Journal of Clinical Oncology 41 ( 3) 541 -541
40
2023
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study
David C Qian , Troy Kleber , Brianna Brammer , Karen M Xu
The Lancet Oncology 22 ( 12) 1777 -1786
103
2021
Residence Proximity to Benzene Release Sites Is Associated with Increased Incidence of Non-Hodgkin Lymphoma.
Catherine Bulka , Loretta J Nastoupil , William McClellan , Alexander Ambinder
Blood 120 ( 21) 2710 -2710
40
2012
Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy
Matthew J Ferris , Jim Zhong , Jeffrey M Switchenko , Kristin A Higgins
Radiotherapy and Oncology 126 ( 1) 100 -106
30
2018
Racial disparities in diagnostic delay among women with breast cancer
Jasmine M Miller-Kleinhenz , Lindsay J Collin , Rebecca Seidel , Arthi Reddy
Journal of the American College of Radiology 18 ( 10) 1384 -1393
27
2021
NEO-GAP: A phase II single-arm prospective feasibility study of neoadjuvant gemcitabine/cisplatin/nab-paclitaxel for resectable high-risk intrahepatic cholangiocarcinoma.
Shishir K Maithel , Milind M Javle , Amit Mahipal , Bruce Shih-Li Lin
Journal of Clinical Oncology 40 ( 16_suppl) 4097 -4097
21
2022
Drivers of racial, regional, and socioeconomic disparities in late‐stage breast cancer mortality
Leah Moubadder , Lindsay J Collin , Rebecca Nash , Jeffrey M Switchenko
Cancer 128 ( 18) 3370 -3382
15
2022
NEO-GAP: A single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma
Shishir K Maithel , Jessica M Keilson , Hop S Tran Cao , Manali Rupji
Annals of surgical oncology 30 ( 11) 6558 -6566
14
2023
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
M Hope Robinson , Nancy Y Villa , David L Jaye , Ajay K Nooka
Journal of Clinical Investigation 133 ( 15) e167629 -e167629
10
2023
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
Yazeed Sawalha , Subir Goyal , Jeffrey M Switchenko , Jason T Romancik
Blood advances 7 ( 13) 2983 -2993
9
2023
Treatment out-of-pocket cost communication and remote financial navigation in patients with cancer: a feasibility study
Gelareh Sadigh , Debrua Coleman , Jeffrey M Switchenko , Judith O Hopkins
Supportive Care in Cancer 30 ( 10) 8173 -8182
9
2022
Receipt of guideline-concordant care does not explain breast cancer mortality disparities by race in metropolitan Atlanta
Lindsay J Collin , Ming Yan , Renjian Jiang , Keerthi Gogineni
Journal of the National Comprehensive Cancer Network 19 ( 11) 1242 -1251
9
2021